NextCell Pharma AB
F:65G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NextCell Pharma AB
F:65G
|
SE |
|
S
|
Salesforce Inc
XBER:FOO
|
US |
|
A
|
Allianz SE
XMUN:ALV
|
DE |
|
D
|
Draganfly Inc
NASDAQ:DPRO
|
CA |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
F
|
Forestar Group Inc
F:4F31
|
US |
|
Mediobanca Banca di Credito Finanziario SpA
MIL:MB
|
IT |
|
B
|
Bank of America Corp
SIX:BAC
|
US |
|
Microvast Holdings Inc
NASDAQ:MVST
|
US |
|
E
|
Ensign Group Inc
F:EGB
|
US |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
Novartis AG
SIX:NOVN
|
CH |
Shareholder Yield
Current shareholder yield for 65G is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
65G Price
NextCell Pharma AB
| Average Annual Return | -32.21% |
| Standard Deviation of Annual Returns | 33.81% |
| Max Drawdown | -97% |
| Market Capitalization | 122.6m EUR |
| Shares Outstanding | 119 937 995 |
| Percentage of Shares Shorted |
N/A
|
